Euclidean Capital LLC

Insider Reports History

Entity
Company
Location
160 Fifth Ave, 9 Th Fl, New York, NY
Signature
/s/ Joseph Cosmai - Euclidean Capital LLC, By: Joseph Cosmai, Manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Euclidean Capital LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PMV Pharmaceuticals, Inc. 10%+ Owner Common Stock 127K $283K $2.23 Jun 14, 2021 Indirect

Insider Reports Filed by Euclidean Capital LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PMVP PMV Pharmaceuticals, Inc. Jun 11, 2021 10 -$2.26M 4 Jun 15, 2021 10%+ Owner
PMVP PMV Pharmaceuticals, Inc. Jun 9, 2021 10 -$2.01M 4 Jun 11, 2021 10%+ Owner
PMVP PMV Pharmaceuticals, Inc. Jun 7, 2021 10 -$2.09M 4 Jun 9, 2021 10%+ Owner
PMVP PMV Pharmaceuticals, Inc. Apr 28, 2021 0 $0 3 May 7, 2021 10%+ Owner